XML 31 R21.htm IDEA: XBRL DOCUMENT v3.7.0.1
Nature of Operations, Basis of Presentation and Significant Accounting Policies (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended
Nov. 15, 2016
Apr. 30, 2016
Feb. 29, 2016
Nov. 30, 2016
Mar. 31, 2017
Dec. 31, 2016
Mar. 31, 2016
Dec. 31, 2015
Common stock, issued         97,099,877 89,771,379    
Accounts payable         $ 618,756 $ 663,261    
Accrued expenses         717,547 1,393,521    
Due to related party         200,333 83,166    
Accrued Interest Payable         21,225      
Sale of common stock to related party, shares   470,000 210,000          
Stock issued during period, value         250,000      
Accumulated deficit         3,033,860 1,951,082    
Negative working         2,297,576      
Cash balance         $ 216,441 105,347 $ 81,941 $ 261,848
Warrant[Member]                
Warrants to purchase shares         300,000      
Stock price         $ 0.28      
Warrant[Member] | Minimum [Member]                
Fair value of exercise price per share         $ 0.28      
Fair value of volatility rate         123.00%      
Fair value of contractual lives         2 years 6 months      
Fair value of risk free rates         0.62%      
Warrant[Member] | Maximum [Member]                
Sale of common stock to related party, shares         3,153,211      
Fair value of exercise price per share         $ 0.75      
Fair value of volatility rate         184.00%      
Fair value of contractual lives         6 years      
Fair value of risk free rates         1.93%      
Line Letter [Member] | Chairman Of Board [Member]                
Line of credit current borrowing capacity $ 540,000         $ 250,000    
Line Letter [Member] | Trieu [Member]                
Line of credit $ 250,000       $ 475,064      
Line of credit, percentage 5.00%              
Debt conversion description Dr. Trieu has the right, exercisable by delivery of written notice thereof (the “Election Notice”), to either: (i) receive repayment for the entire unpaid principal amount advanced under the Line Letter and the accrued and unpaid interest thereon on the date of the delivery of the Election Notice (the “Outstanding Balance”) or (ii) convert the Outstanding Balance into such number of shares of our common stock as is equal to the quotient obtained by dividing (x) the Outstanding Balance by (y) $0.10 (such price, the “Conversion Price”); provided, that in no event shall the Conversion Price be lower than the lower of (x) $0.28 per share or (y) the lowest exercise price of any securities that have been issued by us in a capital raising transaction (and that would otherwise reduce the exercise price of any other outstanding warrants issued by us) during the period between November 15, 2016 and the date of the delivery of the Election Notice. No capital raising transactions have occurred through the date of this filing with securities at a price lower than $0.28 per share.              
IthenaPharma Inc [Member]                
Common stock, issued 58,392,828              
Ownership percentage of issued and outstanding shares 65.00%              
Warrants to purchase shares 300,000              
Maximum percentage of subsequent to the merger 50.00%              
Purchase price of reserve merger consideration $ 3,700,000              
IthenaPharma Inc [Member] | Related Party [Member]                
Estimated purchase allocation and goodwill valuation         55,246      
Estimated purchase allocation and goodwill valuation merger date         $ 1,238,000      
Investment 479              
Accounts payable 71,560              
Accrued expenses 11,470              
Due to related party 5,375              
Other liabilities 118,759              
Convertible note 50,000              
Accrued Interest Payable 567              
Contributed capital $ 257,252              
Novosom Verwaltungs GmbH [Member] | Asset Purchase Agreement [Member]                
Sale of common stock to related party, shares 1,500,000              
Novosom Verwaltungs GmbH [Member] | License Agreement [Member]                
Sale of common stock to related party, shares       119,048        
Stock issued during period, value       $ 15,000